Rheumatoid Arthritis

Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis
Desirée van der Heijde, Michael Schiff, Yoshiya Tanaka, Li Xie, Gabriella Meszaros, Taeko Ishii, Marta Casillas, Robert A Ortmann, Paul Emery

RMD Open May 2019, 5 (1) e000898; DOI: 10.1136/rmdopen-2019-000898
Associations between antenatal prednisone exposure and long-term cortisol and cortisone concentrations in children born to women with rheumatoid arthritis: results from a nationwide prospective cohort study
Hilal Ince-Askan, Erica L T van den Akker, Yolanda B de Rijke, Elisabeth F C van Rossum, Johanna M W Hazes, Radboud J E M Dolhain

RMD Open Jan 2019, 5 (1) e000852; DOI: 10.1136/rmdopen-2018-000852
Era of biosimilars in rheumatology: reshaping the healthcare environment
Josef S Smolen, Joao Goncalves, Mark Quinn, Fabrizio Benedetti, Jake Yongkwon Lee

RMD Open May 2019, 5 (1) e000900; DOI: 10.1136/rmdopen-2019-000900
Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial
Laurette van Boheemen, Samina Turk, Marian van Beers-Tas, Wouter Bos, Diane Marsman, Ed N Griep, Mirian Starmans-Kool, Calin D Popa, Alper van Sijl, Maarten Boers, Michael T Nurmohamed, Dirkjan van Schaardenburg

RMD Open Mar 2021, 7 (1) e001591; DOI: 10.1136/rmdopen-2021-001591
Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial
Juliana Rachel Hoeper, Jan Zeidler, Sara Eileen Meyer, Georg Gauler, Patricia Steffens-Korbanka, Martin Welcker, Jörg Wendler, Florian Schuch, Ulrich von Hinüber, Andreas Schwarting, Torsten Witte, Dirk Meyer-Olson, Kirsten Hoeper

RMD Open Apr 2021, 7 (1) e001627; DOI: 10.1136/rmdopen-2021-001627
Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies
Roy Fleischmann, Jürgen Wollenhaupt, Liza Takiya, Anna Maniccia, Kenneth Kwok, Lisy Wang, Ronald F van Vollenhoven

RMD Open Dec 2017, 3 (2) e000491; DOI: 10.1136/rmdopen-2017-000491
Use of corticosteroids in patients with rheumatoid arthritis treated with infliximab: treatment implications based on a real-world Canadian population
Boulos Haraoui, Algis Jovaisas, William G Bensen, Rafat Faraawi, John Kelsall, Sanjay Dixit, Jude Rodrigues, Maqbool Sheriff, Emmanouil Rampakakis, John S Sampalis, Allen J Lehman, Susan Otawa, Francois Nantel, May Shawi

RMD Open Apr 2015, 1 (1) e000078; DOI: 10.1136/rmdopen-2015-000078
A quarter of patients time their early rheumatoid arthritis onset differently than physicians
Leah Ellingwood, Fatima Kudaeva, Orit Schieir, Susan J Bartlett, Louis Bessette, Gilles Boire, Glen S Hazlewood, Carol Hitchon, Edward Keystone, Diane Tin, Carter Thorne, Vivian P Bykerk, Janet Pope

RMD Open Nov 2019, 5 (2) e000931; DOI: 10.1136/rmdopen-2019-000931
Occupational exposure to organic dusts and risk of developing rheumatoid arthritis: findings from a Swedish population-based case–control study
Anna Ilar, Per Gustavsson, Pernilla Wiebert, Lars Alfredsson

RMD Open Nov 2019, 5 (2) e001049; DOI: 10.1136/rmdopen-2019-001049
Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice
Niels W Boone, Alexandre Sepriano, Paul-Hugo van der Kuy, Rob Janknegt, Ralph Peeters, Robert B M Landewé

RMD Open Nov 2019, 5 (2) e001050; DOI: 10.1136/rmdopen-2019-001050

Main menu

Rheumatoid Arthritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Rheumatoid Arthritis

Pages